Abstract
We used the immature rat uterotrophic assay to determine the estrogenicity of bisphenol A (BPA). We administered BPA (in sesame oil) to rats subcutaneously (sc; 0, 8, 40, and 160 mg/kg/day) or orally (0, 40, 160, and 800 mg/kg/day) for 3 days beginning on postnatal day (PND) 18; rats were sacrificed 24 hr after the last administration. Uterine wet, blotted, and relative weights increased in all groups given BPA sc. After oral administration, uterine relative weight increased in 160 and 800 mg/kg BPA groups, and wet and blotted weights increased in the 800 mg/kg BPA group. Plasma concentrations of BPA at 1 hr after the last administration were detected in all groups given BPA sc and in groups given 160 and 800 mg/kg BPA orally, with a dose-response effect. The study was then reproduced under the same conditions. After sc injections, uterine wet and blotted weights increased in the 40 and 160 mg/kg BPA groups, and relative weight increased in all groups given BPA sc. By contrast, uterine wet, blotted, and relative weights increased only in the 160 and 800 mg/kg oral BPA groups. Also, to examine time-course changes in uterine weight, we administered BPA (in sesame oil) sc from PND 18 to PND 20 for 3 days at doses of 0, 8, 40, and 160 mg/kg/day; uterine weights were then measured at 6, 12, 18, and 24 hr after the last administration. Uterine wet, blotted, and relative weights increased in all BPA groups at 6 and 24 hr and in 40 and 160 mg/kg BPA groups at 12 hr. By contrast, at 18 hr, uterine wet, blotted, and relative blotted weights increased in all BPA groups and relative wet weight increased in 40 and 160 mg/kg BPA groups. The percentage increases in uterine wet and relative weights of 40 and 160 mg/kg BPA groups at 6 hr were higher than those at 24 hr relative to the controls, but the coefficient of variation in these weights in the group given 8 mg/kg BPA at 24 hr was smaller than that at 6 hr. These findings demonstrate BPA-induced uterotrophy in the immature uterotrophic assay in rats administered 8 mg/kg/day sc and in rats given 160 mg/kg/day orally, and suggest that the autopsy at 24 hr after the last administration is suitable.
Full Text
The Full Text of this article is available as a PDF (63.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashby J., Elliott B. M. Reproducibility of endocrine disruption data. Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):94–95. doi: 10.1006/rtph.1997.1157. [DOI] [PubMed] [Google Scholar]
- Ashby J., Tinwell H. Uterotrophic activity of bisphenol A in the immature rat. Environ Health Perspect. 1998 Nov;106(11):719–720. doi: 10.1289/ehp.98106719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Branham W. S., Zehr D. R., Chen J. J., Sheehan D. M. Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology. 1988 Oct;51(2-3):201–212. doi: 10.1016/0300-483x(88)90150-3. [DOI] [PubMed] [Google Scholar]
- Branham W. S., Zehr D. R., Sheehan D. M. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med. 1993 Jul;203(3):297–303. doi: 10.3181/00379727-203-43602. [DOI] [PubMed] [Google Scholar]
- Feldman D., Krishnan A. Estrogens in unexpected places: possible implications for researchers and consumers. Environ Health Perspect. 1995 Oct;103 (Suppl 7):129–133. doi: 10.1289/ehp.95103s7129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaido K. W., Leonard L. S., Lovell S., Gould J. C., Babaï D., Portier C. J., McDonnell D. P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol. 1997 Mar;143(1):205–212. doi: 10.1006/taap.1996.8069. [DOI] [PubMed] [Google Scholar]
- Gould J. C., Leonard L. S., Maness S. C., Wagner B. L., Conner K., Zacharewski T., Safe S., McDonnell D. P., Gaido K. W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol. 1998 Jul 25;142(1-2):203–214. doi: 10.1016/s0303-7207(98)00084-7. [DOI] [PubMed] [Google Scholar]
- Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
- McLachlan J. A. Functional toxicology: a new approach to detect biologically active xenobiotics. Environ Health Perspect. 1993 Oct;101(5):386–387. doi: 10.1289/ehp.93101386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLachlan J. A., Korach K. S. Symposium on estrogens in the environment, III. Environ Health Perspect. 1995 Oct;103 (Suppl 7):3–4. doi: 10.1289/ehp.95103s73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Connor J. C., Cook J. C., Craven S. C., Van Pelt C. S., Obourn J. D. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam Appl Toxicol. 1996 Oct;33(2):182–195. [PubMed] [Google Scholar]
- Odum J., Lefevre P. A., Tittensor S., Paton D., Routledge E. J., Beresford N. A., Sumpter J. P., Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol. 1997 Apr;25(2):176–188. doi: 10.1006/rtph.1997.1100. [DOI] [PubMed] [Google Scholar]
- Olea N., Pulgar R., Pérez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A. M., Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect. 1996 Mar;104(3):298–305. doi: 10.1289/ehp.96104298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reel J. R., Lamb IV J. C., Neal B. H. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol. 1996 Dec;34(2):288–305. doi: 10.1006/faat.1996.0198. [DOI] [PubMed] [Google Scholar]